| Diana L Defelice, DO | |
|
13616 E 103rd St N, Ste A, Owasso, OK 74055-4586 | |
| (918) 274-8555 | |
| (918) 274-8556 |
| Full Name | Diana L Defelice |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 13616 E 103rd St N, Owasso, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649262270 | NPI | - | NPPES |
| 100768880I | Other | OK | SONICARE MEDICAID |
| 100088200B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2160 (Oklahoma) | Primary |
| Entity Name | St John Urgent Care Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003918830 PECOS PAC ID: 5890898084 Enrollment ID: O20070308000190 |
News Archive
ZO Skin Health By Zein Obagi, M.D. is pleased to announce the global launch of a new comprehensive medical skincare line, ZO Medical, at the American Academy of Dermatology Annual Meeting.
Children affected by cancer have received new hope, with Cancer Council research revealing those who survive at least five years after diagnosis are likely to enjoy long term survival similar to that of children without cancer.
A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online today in Nature, could lead to ways to manipulate this process to improve the immune system's ability to combat viral infections, such as those fueling the ongoing COVID-19 pandemic.
Ovizio Imaging System, an innovative quantitative microscopy company specializing in life science solutions, announces today the launch of its new product, the iLine F, an in-line suspension cell-monitoring microscope.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana L Defelice, DO 1717s Utica Ave A, Tulsa, OK 74104-5346 Ph: (918) 748-1300 | Diana L Defelice, DO 13616 E 103rd St N, Ste A, Owasso, OK 74055-4586 Ph: (918) 274-8555 |
News Archive
ZO Skin Health By Zein Obagi, M.D. is pleased to announce the global launch of a new comprehensive medical skincare line, ZO Medical, at the American Academy of Dermatology Annual Meeting.
Children affected by cancer have received new hope, with Cancer Council research revealing those who survive at least five years after diagnosis are likely to enjoy long term survival similar to that of children without cancer.
A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online today in Nature, could lead to ways to manipulate this process to improve the immune system's ability to combat viral infections, such as those fueling the ongoing COVID-19 pandemic.
Ovizio Imaging System, an innovative quantitative microscopy company specializing in life science solutions, announces today the launch of its new product, the iLine F, an in-line suspension cell-monitoring microscope.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
› Verified 1 days ago
Bryan Vannuel Marsh, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 13616 E 103rd Street N, Suite A, Owasso, OK 74055 Phone: 918-274-8555 Fax: 918-274-8556 | |
Dr. David Lee Smith, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 13600 E 86th St N, Ste 100, Owasso, OK 74055 Phone: 918-272-9313 Fax: 918-403-6311 | |
Sharon Sodano Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13600 E 86th St N, Owasso, OK 74055 Phone: 918-272-2247 | |
Dr. Jack Robin Snedden Iii, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 10502 North 110th East Avenue, Owasso, OK 74055 Phone: 918-376-8590 Fax: 918-376-8549 | |
Dr. Keith Stacy Patterson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10512 North 110th East Avenue, Owasso, OK 74055 Phone: 918-376-8900 Fax: 918-272-7475 | |
Chelsea Leigh Mcdonald, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 8551 N 125th East Ave Ste 175, Owasso, OK 74055 Phone: 918-265-3797 | |
Caleb Nunley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12455 E 100th St N, Ste. 120, Owasso, OK 74055 Phone: 918-272-9464 Fax: 918-272-9512 |